1. Home
  2. PGEN vs GRAF Comparison

PGEN vs GRAF Comparison

Compare PGEN & GRAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • GRAF
  • Stock Information
  • Founded
  • PGEN 1998
  • GRAF 2021
  • Country
  • PGEN United States
  • GRAF United States
  • Employees
  • PGEN N/A
  • GRAF N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • GRAF
  • Sector
  • PGEN Health Care
  • GRAF
  • Exchange
  • PGEN Nasdaq
  • GRAF NYSE
  • Market Cap
  • PGEN 292.6M
  • GRAF 288.9M
  • IPO Year
  • PGEN N/A
  • GRAF 2024
  • Fundamental
  • Price
  • PGEN $0.80
  • GRAF $10.09
  • Analyst Decision
  • PGEN Buy
  • GRAF
  • Analyst Count
  • PGEN 5
  • GRAF 0
  • Target Price
  • PGEN $7.00
  • GRAF N/A
  • AVG Volume (30 Days)
  • PGEN 930.1K
  • GRAF 40.5K
  • Earning Date
  • PGEN 11-14-2024
  • GRAF 01-01-0001
  • Dividend Yield
  • PGEN N/A
  • GRAF N/A
  • EPS Growth
  • PGEN N/A
  • GRAF N/A
  • EPS
  • PGEN N/A
  • GRAF 0.25
  • Revenue
  • PGEN $3,963,000.00
  • GRAF N/A
  • Revenue This Year
  • PGEN N/A
  • GRAF N/A
  • Revenue Next Year
  • PGEN $426.76
  • GRAF N/A
  • P/E Ratio
  • PGEN N/A
  • GRAF $40.59
  • Revenue Growth
  • PGEN N/A
  • GRAF N/A
  • 52 Week Low
  • PGEN $0.76
  • GRAF $9.03
  • 52 Week High
  • PGEN $1.93
  • GRAF $11.02
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 42.83
  • GRAF N/A
  • Support Level
  • PGEN $0.76
  • GRAF N/A
  • Resistance Level
  • PGEN $0.97
  • GRAF N/A
  • Average True Range (ATR)
  • PGEN 0.06
  • GRAF 0.00
  • MACD
  • PGEN -0.01
  • GRAF 0.00
  • Stochastic Oscillator
  • PGEN 20.52
  • GRAF 0.00

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About GRAF GRAF GLOBAL CORP

Graf Global Corp is a blank check company.

Share on Social Networks: